3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
2
Neuralgia
2
Neoplasms
2
Lung Neoplasms
2
Leiomyoma
2
Sexual Dysfunction, Physiological
1
Scleroderma, Localized
1
Pneumonia
1
Pain
1
Neuropathy, Painful
1
Neurofibromatoses
1
Neurodermatitis
1
Neoplasms, Cystic, Mucinous, and Serous
1
Mastodynia
1
Lymphoma, Follicular
1
Lichen Planus
1
Leukemia-Lymphoma
1
Kidney Neoplasms
1
Keratoacanthoma
1
Keloid
1
Ileus
1
Hydrocephalus
1
Hordeolum
1
Headache
1
Granuloma Annulare
1
Eyelid Neoplasms
1
Epilepsy
1
Dermoid Cyst
1
Colorectal Neoplasms
1
Cold Hypersensitivity
1
Interventions
Temozolomide
53
Bevacizumab
45
Radiotherapy
28
Radiosurgery
21
Carboplatin
14
Erlotinib Hydrochloride
11
Radiation
10
pembrolizumab
9
Magnetic Resonance Spectroscopy
9
Etoposide
9
Vorinostat
8
Trastuzumab
8
Irinotecan
8
Sunitinib
7
Sorafenib
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Lapatinib
7
Capecitabine
7
dabrafenib
6
Ipilimumab
6
Imatinib Mesylate
6
Cyclophosphamide
6
Sirolimus
5
Hydroxyurea
5
Everolimus
5
Bortezomib
5
temsirolimus
4
cabozantinib
4
binimetinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Brain Neoplasms
×
Lidocaine
×
Clear all
No trials found.